-
Evaluating Fixed-Duration Regimens in Chronic Lymphocytic Leukemia
02 Feb 2026 15:53 GMT
… of FD regimens in chronic lymphocytic leukemia encapsulates the broader narrative … : Fixed-Duration Regimens in Chronic Lymphocytic Leukemia
Article Title: Have Fixed … s12325-025-03486-z
Keywords: Chronic Lymphocytic Leukemia, Fixed-Duration Regimens, Oncology …
-
Unexpected RNA Role Discovered Inside Protein-Coding Gene
03 Feb 2026 16:20 GMT
… blood cancers: multiple myeloma and chronic lymphocytic leukemia. They found that patients with …
-
Rare-Disease, Cancer Drugs Get Cheaper
03 Feb 2026 07:21 GMT
… portfolios benefit via Venetoclax for chronic lymphocytic leukemia.
Other global players with products …
-
Novel RNA molecule may influence patient survival in certain blood cancers
03 Feb 2026 02:49 GMT
… blood cancers: multiple myeloma and chronic lymphocytic leukemia. They found that patients with …
-
Scientists Discover New RNA Associated with Cancer Patient Survival
02 Feb 2026 23:24 GMT
… patients with multiple myeloma and chronic lymphocytic leukemia, the researchers discovered that elevated …
-
3 Stocks to Buy in February
02 Feb 2026 09:10 GMT
… (MCL) and R/R chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma …
-
<![CDATA[Most Patients With MCL in Study of Pirtobrutinib Show Stable or Improved Physical Symptoms, QOL]]>
01 Feb 2026 02:47 GMT
… data for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma … mantle cell lymphoma or chronic lymphocytic leukemia receiving pirtobrutinib in the … approval to pirtobrutinib for chronic lymphocytic leukemia and small lymphocytic lymphoma. …
-
<![CDATA[Real-World Data Support Zanubrutinib Use in Older Patients With CLL: Margaret Krackeler, MD]]>
31 Jan 2026 14:49 GMT
… and outcomes in patients with chronic lymphocytic leukemia (CLL), with particular focus on … and outcomes of zanubrutinib in chronic lymphocytic leukemia and small lymphocytic leukemia (CLL …
-
Wall Street Bullish on BeOne Medicines AG (ONC) amid Robust Pipeline Development
31 Jan 2026 14:47 GMT
… plus rituximab, in treatment-naïve chronic lymphocytic leukemia. Sonrotoclax, its BCL2 inhibitor, has …
-
<![CDATA[Indirect Comparison Supports Zanubrutinib Monotherapy in CLL/SLL Care]]>
31 Jan 2026 00:29 GMT
… ) among patients with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma … -duration acalabrutinib combinations in untreated chronic lymphocytic leukemia. N Engl J Med. 2025 …